BRAIN TUMOR, RECURRENT
Clinical trials for BRAIN TUMOR, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new BRAIN TUMOR, RECURRENT trials appear
Sign up with your email to follow new studies for BRAIN TUMOR, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves and radiation team up against returning brain tumors
Disease control CompletedThis small pilot study tested whether combining focused ultrasound with a second round of radiation is safe for people with recurrent glioblastoma, an aggressive brain cancer. Seven adults who had already tried standard treatments received the combination therapy. The goal was to…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: NA • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Experimental brain cancer therapy infused directly into tumors shows promise in early trial
Disease control CompletedThis early-phase study tested a new drug called D2C7-IT for people with recurrent malignant glioma, a serious brain cancer. The drug was delivered directly into the tumor through tiny tubes over 72 hours. The main goal was to find the safest dose and see if it could help control …
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New Gadolinium-Free MRI dye could make brain scans safer
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, which does not contain gadolinium, in 18 adults with brain lesions from conditions like tumors or multiple sclerosis. The goal was to see if it is safe and effective at highlighting these lesions compared to standard gado…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated May 17, 2026 03:12 UTC
-
New MRI dye shows promise for spotting brain tumors
Diagnosis CompletedThis study tested a new contrast agent called Elucirem (gadopiclenol) for MRI scans of brain gliomas. It involved 138 adults with new or returning brain tumors. The goal was to see if Elucirem produced better quality images than the standard agent Dotarem. Results showed Elucirem…
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated May 13, 2026 16:01 UTC
-
Glow-in-the-Dark dye helps surgeons spot hidden brain tumors
Knowledge-focused CompletedThis study tested whether a dye called indocyanine green can make brain tumor cells glow during surgery, helping surgeons see and remove them more completely. 363 adults with brain tumors received the dye before surgery, and special cameras were used to detect the glow. The goal …
Matched conditions: BRAIN TUMOR, RECURRENT
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC